In breast cancer (BC) cells, SMYD3 can regulate the cell cycle and promote cancer cell migration by combining with the cyclin A1 (CCNA1) and myosin light chain 9 (MYL9) promoters (Luo et al., 2014; Mazur et al., 2014). This evidence concerns the gene MYL9 and cancer.